CEP304 HCL Outcomes Study
Research payments
$2,186,651
Through program year 2025, $2,186,651 in research payments was reported against CEP304 HCL Outcomes Study, across 391 payments, paid by Medtronic, Inc..
- Paid by
- Medtronic, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $2,125 | 1 |
| 2024 | Research | $29,307 | 21 |
| 2023 | Research | $217,436 | 53 |
| 2022 | Research | $714,367 | 115 |
| 2021 | Research | $1,223,415 | 201 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Gnanagurdasan Prakasam Sacramento, CA Named on 26 payments
- Anuj Bhargava Des Moines, IA Named on 20 payments
- Yogish Kudva Rochester, MN Named on 19 payments
- Linda Di Meglio Indianapolis, IN Named on 19 payments
- Alan Schorr Yardley, PA Named on 17 payments
- Mark Kipnes San Antonio, TX Named on 16 payments
- Irl Hirsch Seattle, WA Named on 14 payments
- David Liljenquist Pocatello, ID Named on 13 payments
- Athena Philis-Tsimikas La Jolla, CA Named on 13 payments
- Rodica Busui Ann Arbor, MI Named on 13 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.